Department of Interventional Radiology
Harbin Medical University Cancer Hospital, Harbin
介入科 · Interventional Radiology
Established in 1990, this department provides interventional diagnosis and treatment for various conditions. The team includes 14 physicians and utilizes equipment such as INNOVA-4100 angiography systems. Services include arterial infusion chemotherapy and chemoembolization for malignancies like lung, liver, pancreatic, gastric, and renal cancers. The department performs stent placement in the bile duct, esophagus, trachea, and colorectal areas. Additional treatments include radiofrequency ablation, CT or ultrasound-guided percutaneous procedures, and iodine-125 seed implantation. In 2013, the department completed over 3,367 interventional surgeries under digital subtraction angiography and more than 400 seed implantations or ablations annually. The unit maintains 90 beds and emphasizes the use of domestic stents.
What the department treats
- Arterial infusion chemotherapy and chemoembolization for tumors
- Stent placement in bile duct, esophagus, trachea, and colorectum
- Radiofrequency ablation and iodine-125 seed implantation
- Interventional treatment for liver, kidney, and adrenal cancers
- Combined therapy with sorafenib for unresectable liver cancer
- Portal vein seed implantation for liver cancer with tumor thrombus
Key facts
- The department was established in 1990 and has treated nearly 30,000 patients.
- The team consists of 40 staff members, including 14 physicians and 23 nurses, with 90 beds available.
- In 2013, the department performed over 3,367 interventional surgeries under DSA and more than 400 ablations or seed implantations.
As described by the hospital.
Team
8 doctors listed, including 4 chief physicians. Its chief physicians have 14 first- or senior-author papers on PubMed since 2016.
| Chief physician | Clinical focus | Key papers since 2016 |
|---|---|---|
| Prof. Ruibao Liu 刘瑞宝 · Professor | Early diagnosis and comprehensive treatment of liver cancer, including interventional therapy, ablation, targeted drugs, and immunotherapy. Lung cancer particle therapy. Stent placement for bile duct, esophageal, and tracheal conditions. | 7 |
| Dr. Ping Wang 王平 · Associate Professor | Interventional treatments for primary and metastatic liver cancer, including mFolfox-based HAIC to downstage inoperable tumors. Management of malignant obstructive jaundice with stenting and HAIC. Radiofrequency ablation for large liver tumors, esophageal stenting, hepatic hemangioma embolization, and HAIC-based targeted immunotherapy. | 5 |
| Prof. Dongfeng He 何东风 · Professor | Early diagnosis and interventional treatment of liver cancer, including radiofrequency ablation, molecular targeted therapy, and radioactive seed implantation for portal vein tumor thrombus. Also treats liver hemangiomas, uterine fibroids, lung, gastric, pancreatic, renal, and cervical cancers, malignant obstructive jaundice, and performs esophageal and biliary stent placement. | 2 |
| Dr. Yan Liu 刘岩 · Associate Professor | Transvascular interventional therapy for liver, lung, gynecologic, gastric, and renal cancers; stent placement for esophageal, tracheal, and bile duct strictures; ultrasound-guided drainage and sclerotherapy for cysts and abscesses; microwave coagulation and alcohol ablation for liver cancer. | checking |
Associate chief physicians
- Dr. Huiwen Wang王惠文
- Dr. Guang Yang杨光
We are an independent coordination service, not part of this hospital. Team data comes from public doctor-listing platforms; publication counts come from PubMed, matched by full name and affiliation, and doctors with very common names are checked by hand before their papers are shown. How we build this directory.
Not sure which specialist is right?
Send your records. We find a specialist in the right field to review your case and write a treatment plan with a cost estimate.
Get a specialist opinion